Serious adverse event after unrecognized substitution of one amphotericin B lipid preparation for another.
Johnson
J R
JR
Kangas
P J
PJ
West
M
M
D000368:Aged; D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects*; D001228:Aspergillosis / Q000188:drug therapy*; D004337:Drug Carriers; D004338:Drug Combinations; D004339:Drug Compounding; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D008297:Male; D010713:Phosphatidylcholines / Q000627:therapeutic use*; D010715:Phosphatidylglycerols / Q000627:therapeutic use*
D000935:Antifungal Agents; D004337:Drug Carriers; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B